One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity
Ophthalmology Retina · 2024
DOI: 10.1016/j.oret.2024.04.008 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Hemal Mehta und 20 weiteren Autor:innen. Beteiligte Einrichtung: The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia; Department of Ophthal…. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Angiogenesis Inhibitors, Intravitreal Injections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, Royal Australian and New Zealand College of Ophthalmologists, Macular Disease Foundation Australia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia; Department of Ophthalmology, Royal Free London NHS Foundation Trust, London, United Kingdom.
- The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia; Department of Ophthalmology, Dijon University Hospital, Dijon, France. Electronic address:…
- The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia.
- Marsden Eye Specialists, Sydney, New South Wales, Australia.
- Department of Ophthalmology, Saint Brieuc Hospital, Saint Brieuc, France.
- Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.
Förderung
- Bayer
- Royal Australian and New Zealand College of Ophthalmologists
- Macular Disease Foundation Australia
- Novartis
- National Health and Medical Research Council
- Roche
Zitieren
APA
Mehta, H., Gabrielle, P. H., Hashimoto, Y., Kibret, G. D., Arnold, J., Guillaumie, T., Kheir, W. J., Kok, G., Vujosevic, S., O'Toole, L., Mangelschots, E., Jaross, N., Ceklic, L., Daien, V., Viola, F., Squirrell, D., Lavid, F. J., Creuzot-Garcher, C., Barthelmes, D., …, & Fight Retinal Blindness! Study Group (2024). One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.04.008
Vancouver
Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, et al. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.04.008
BibTeX
@article{Mehta2024,
author = {Mehta, Hemal and Gabrielle, Pierre-Henry and Hashimoto, Yohei and Kibret, Getiye Dejenu and Arnold, Jennifer and Guillaumie, Tremeur and Kheir, Wajiha Jurdi and Kok, Gerhard and Vujosevic, Stela and O'Toole, Louise and Mangelschots, Els and Jaross, Nandor and Ceklic, Lala and Daien, Vincent and Viola, Francesco and Squirrell, David and Lavid, Francisco Javier and Creuzot-Garcher, Catherine and Barthelmes, Daniel and Gillies, Mark and Fight Retinal Blindness! Study Group, Fight Retinal Blindness! Study Group},
title = {One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity},
journal = {Ophthalmology Retina},
year = {2024},
doi = {10.1016/j.oret.2024.04.008}
}
EUVIMED